SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on January 29, 2008, by India Globalization Capital, Inc. (the "Company"). The filing reports on Item 8.01 (Other Events) regarding the Company's intent to hold investor presentations concerning a proposed business combination. The Company is a Maryland corporation with its principal executive offices in Bethesda, Maryland.
Key Financial Metrics
The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures for the Company. The only specific financial figure disclosed is a contingent expense allowance of $1,769,400 payable to IPO underwriters (Ferris, Baker Watts, Incorporated; Ladenburg Thalmann & Co. Inc.; and Maxim Group, LLC) solely upon the completion of a business combination.
Material Changes and Proposed Transactions
The Company intends to acquire the following assets and equity interests:
- Approximately 63% of the outstanding stock of Sricon Infrastructure Private Limited.
- Approximately 77% of the outstanding stock of Techni Bharathi Limited.
- A 24-mega watt wind energy farm consisting of 96 250-kilowatt wind turbines to be manufactured by Chiranjjeevi Wind Energy Limited, Arul Mariamman Textiles Limited, and Marudhavel Industries Limited.
A preliminary proxy statement has been filed, with a definitive proxy statement planned for future filing.
Guidance, Outlook, and Risks
Management has announced plans to solicit proxies from stockholders to approve the proposed acquisition. The filing identifies current directors, executive officers, and certain nominees as participants in the solicitation. The underwriters from the Company's IPO may assist in these efforts but will not receive additional fees beyond the contingent expense allowance mentioned above. Investors are urged to review the proxy statements for detailed information regarding the transaction and participant interests.
Investor Verification Checklist
- Verify the status and content of the definitive proxy statement once filed with the SEC.
- Confirm the financial health and operational status of the target entities (Sricon Infrastructure, Techni Bharathi, and the wind energy manufacturers).
- Review the Registration Statement on Form S-1 (No. 333-124942) for details on current directors and executive officers.
- Assess the risk that the $1,769,400 underwriter expense allowance will only be triggered if the business combination is successfully completed.